All forms of liraglutide should be used with a reduced-calorie diet and increased physical activity
Key Points The major 23 kDa prolactin isoform exerts its action via a transmembrane receptor, prolactin receptor (PRL-R), which belongs to the class of haematopoietic cytokine receptors Binding of prolactin to its predimerized receptor induces a conformational change in the receptor, which enables signal transduction Hyperprolactinaemia causes hypogonadotropic hypogonadism by inhibiting kisspeptin-1 secretion, which in turn disrupts hypothalamic gonadotropin-releasing hormone I secretion The first germline loss-of-function mutation in the gene that encodes PRL-R was reported in three sisters with familial idiopathic hyperprolactinaemia The 16 kDa isoform of prolactin has antitumoral and antiangiogenic actions and is involved in peripartum cardiomyopathy Abstract Prolactin is a hormone that is mainly secreted by lactotroph cells of the anterior pituitary gland, and is involved in many biological processes including lactation and reproduction
Long-term safety data for topical formulations are currently lacking
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia
Heres what that might look like: Starting dose: 2.5 mg weekly (weeks 1 through 4) Dose escalation: Increase as needed and tolerated, typically every 4 weeks: 5 mg weekly 7.5 mg weekly 10 mg weekly 12.5 mg weekly 15 mg weekly Maintenance dose: Any dose can be used for maintenance if it works for you
Do not extend fasting beyond what is recommended, as this may lead to dehydration or hypoglycaemia
